Rising temperatures may increase the severity of obstructive sleep apnea (OSA), according to a large new study presented at ...

Experts explain the two types of sleep apnea and how symptoms such as daytime sleepiness can reveal your diagnosis ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Greater obstructive sleep apnea-related hypoxemia is associated with frontoparietal cerebrovascular pathology.

IHL-42X is designed to treat obstructive sleep apnea ("OSA”) by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing ...

Brown, MD, and Victoria Francois, MPH, discuss strategies to address the gap in sleep inequalities affecting Black women.

IXHL Stock - Incannex Healthcare’s shares surged 876% after completing patient dosing in the Phase 2 trial of its oral sleep ...

The company completed patient dosing in its Phase 2/3 trial for IHL-42X, a once-daily oral treatment for obstructive sleep ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

In children with OSA, circadian blood pressure dysregulation is associated with impaired cardiac function, especially diastolic dysfunction.